✦ LIBER ✦

PCN8 AVERAGE TOTAL COST OF TREATING ADVANCED NON-SMALL-CELL LUNG CANCER PATIENTS IN SPAIN USING VARIOUS CHEMOTHERAPY DOUBLETS

✍ Scribed by A Kielhorn; M Aristides; DP Tilden; S Bhalla

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN58 A COST UTILITY ANALYSIS OF ERLOTIN

✍ PA Bradbury; R Jang; P Isogai; R Ng; N Mittmann; W Evans; FA Shepherd; NB Leighl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PCN30 IMPROVED TOXICITY PROFILE OF PEMET

✍ G Stynes; M Aristides; R Rosell; E Felip; AM Liepa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PCN20 COSTS OF TREATING ADVANCED NON-SMA

✍ A Kielhorn; T Dilla; G Stynes; D Tilden; S Bhalla 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Prognostic significance of total lesion

✍ Yoshiaki Zaizen; Koichi Azuma; Seiji Kurata; Eiji Sadashima; Satoshi Hattori; Te 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 240 KB

PCN8 COST-EFFECTIVENESS OF ADJUVANT CHEM

✍ S Ikeda; H Sakamaki; S Yajima; N Ikegami 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

PCN75 COST-EFFECTIVENESS ANALYSIS OF EGF

✍ O Arrieta; P Anaya; RJ López; AC Polanco 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB